ICI-164384

ICI-164384 is a nonsteroidal anti-inflammatory drug (NSAID) that was never marketed. It is a cyclooxygenase inhibitor.

Pharmacology

ICI-164384 is a cyclooxygenase inhibitor, more specifically, it is a cyclooxygenase 2 inhibitor. Cyclooxygenase 2 is an enzyme that is responsible for the formation of prostanoids, including prostaglandins, prostacyclin and thromboxane. By inhibiting this enzyme, ICI-164384 can reduce the production of these prostanoids and thus reduce inflammation and pain.

History

ICI-164384 was developed by Imperial Chemical Industries (ICI), a British chemical company. Despite its potential as a nonsteroidal anti-inflammatory drug, it was never marketed.

See also

• Nonsteroidal anti-inflammatory drug
• Cyclooxygenase 2
• Imperial Chemical Industries

References

ICI-164384 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski